Evaluating Industry Payments Among Dermatology Clinical Practice Guideline Authors—Reply

In Reply We appreciate the opportunity to respond to Glazer et al regarding our recent publication on financial conflicts of interest (COIs). This issue is timely, important, and needs addressing. We will respond to their 2 primary criticisms. First, they proffer that research payments should not be considered COIs owing to the importance of physician-industry relationships in advancing medical knowledge. Second, they contend that the Open Payments Database (OPD) is "flawed," and thus our findings lack merit. We address these criticisms herein.